Saturday, March 02, 2013 9:05:51 AM
One can see from the link you provided in your last post that the informative article you linked to substantiates my earlier comments about suppository medication for pain relief and other issues in the EU currently being ahead of us in the USA. It avoids negative side-effects and organ damage. It also seems to me to be a natural progression that people in the EU will gravitate away from suppositories to patches. Another huge opportunity for BIEL.
If only the FDA could catch up in the device pain relief field, it would help millions of people to avoid ingesting chemicals, not just the shareholders of BIEL.
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM